Collinsville, IL, United States of America

Frances K Newman

This inventor holds 1 USPTO granted patent. Top assignee: Saint Louis University. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frances K Newman. Retrieved from https://idiyas.com/inventor/frances-k-newman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frances K Newman: Innovator in Vaccine Development

Introduction

Frances K Newman is a notable inventor based in Collinsville, IL (US). She has made significant contributions to the field of vaccine development, particularly in the area of viral strains that can be used for immunization purposes. Her work has implications for public health and the prevention of viral infections.

Latest Patents

Frances K Newman holds a patent for a temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus. The present invention relates to isolated, attenuated viral strains of human parainfluenza virus 2 (HPIV-2), which are useful in live vaccine preparations. These strains exhibit a temperature-sensitive and cold-adapted phenotype useful for stimulating a protective immune response in an inoculated mammal without producing severe symptoms. She has 1 patent to her name.

Career Highlights

Frances K Newman is affiliated with Saint Louis University, where she conducts her research and contributes to advancements in vaccine technology. Her work is critical in developing safer and more effective vaccines for various viral infections.

Collaborations

One of her notable collaborators is Robert B Belshe, who has worked alongside her in the field of vaccine research.

Conclusion

Frances K Newman is a pioneering inventor whose work in vaccine development is making a significant impact on public health. Her innovative approaches to creating effective vaccines demonstrate her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…